• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌患者生存与放射学-病理学不一致的相关性:一项基于韩国原发性肝癌登记处的全国性队列研究

Association of Survival with Radiologic-Pathologic Discordance in Patients with Hepatocellular Carcinoma: A Nationwide Cohort Study Based on the Primary Liver Cancer Registry in Korea.

作者信息

Rou Woo Sun, Jeon Hong Jae, Eun Hyuk Soo, Lee Hyun Seok, Park Jae Ho, Joo Jong Seok, Kim Ju Seok, Lee Eaum Seok, Kim Seok Hyun, Lee Jeong Eun, Shin Kyung Sook, Kim Seok-Hwan, Yeo Min-Kyung, Lee Ju-Mi, Kwon In Sun, Lee Byung Seok

机构信息

Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chungnam National University Sejong Hospital, Sejong, Korea.

出版信息

Gut Liver. 2025 Jul 15;19(4):602-616. doi: 10.5009/gnl240393. Epub 2025 Apr 1.

DOI:10.5009/gnl240393
PMID:40169392
Abstract

BACKGROUND/AIMS: No studies have investigated the effects of radiologic-pathologic discordance on the outcomes of patients who have undergone resection for hepatocellular carcinoma (HCC). Therefore, we investigated the effects of these discrepancies on the outcomes of such patients.

METHODS

This study included patients diagnosed with HCC on magnetic resonance imaging who underwent resection, including 1,790 from the Korean Primary Liver Cancer Registry (nationwide cohort) and 185 from Chungnam National University Hospital (hospital cohorts). Radiologic-pathologic discrepancies in five factors (maximum tumor diameter, tumor number, vascular invasion, bile duct invasion, and lymph node metastasis) were evaluated using Kaplan-Meier and Cox regression analyses.

RESULTS

The survival rate in the nationwide cohort was lower when all five factors were discordant than when all were concordant (p<0.001). A similar trend was observed in the hospital cohort; however, it was not statistically significant (p=0.260). In multivariate analyses, radiologicpathologic discrepancies in more than two factors (hazard ratio [HR], 3.251) and vascular invasion (HRs, 2.044 and 2.596), and lymph node metastasis (HRs, 8.157 and 7.209) on pathology or both imaging and pathology, respectively, were independent predictors of survival (all p<0.001). Similarly, lymph node metastasis on imaging emerged as an independent predictor (HR, 3.386; p=0.009). Age, an alpha-fetoprotein ≥200 ng/mL, and a modified Union for International Cancer Control stage were additional independent predictors.

CONCLUSIONS

This is the first study to demonstrate that radiologic-pathologic discordance in patients with HCC who have undergone resection are significantly associated with worse survival. More accurate and appropriate preoperative evaluations are essential for optimizing treatment and improving prognosis.

摘要

背景/目的:尚无研究调查放射学-病理学不一致对接受肝细胞癌(HCC)切除术患者预后的影响。因此,我们研究了这些差异对此类患者预后的影响。

方法

本研究纳入了经磁共振成像诊断为HCC并接受切除术的患者,其中包括来自韩国原发性肝癌登记处的1790例(全国队列)和忠南国立大学医院的185例(医院队列)。使用Kaplan-Meier和Cox回归分析评估五个因素(最大肿瘤直径、肿瘤数量、血管侵犯、胆管侵犯和淋巴结转移)的放射学-病理学差异。

结果

在全国队列中,所有五个因素均不一致时的生存率低于所有因素均一致时(p<0.001)。在医院队列中也观察到类似趋势;然而,差异无统计学意义(p=0.260)。在多因素分析中,两个以上因素的放射学-病理学差异(风险比[HR],3.251)以及病理学上的血管侵犯(HR分别为2.044和2.596)和淋巴结转移(HR分别为8.157和7.209),或影像学和病理学两者上的差异,均是生存的独立预测因素(所有p<0.001)。同样,影像学上的淋巴结转移也是独立预测因素(HR,3.386;p=0.009)。年龄、甲胎蛋白≥200 ng/mL以及国际癌症控制联盟改良分期是其他独立预测因素。

结论

这是第一项证明接受切除术的HCC患者的放射学-病理学不一致与较差生存率显著相关的研究。更准确和适当的术前评估对于优化治疗和改善预后至关重要。

相似文献

1
Association of Survival with Radiologic-Pathologic Discordance in Patients with Hepatocellular Carcinoma: A Nationwide Cohort Study Based on the Primary Liver Cancer Registry in Korea.肝细胞癌患者生存与放射学-病理学不一致的相关性:一项基于韩国原发性肝癌登记处的全国性队列研究
Gut Liver. 2025 Jul 15;19(4):602-616. doi: 10.5009/gnl240393. Epub 2025 Apr 1.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Impact of disparity between imaging and pathological tumor size on cancer-specific prognosis among patients with hepatocellular carcinoma.肝细胞癌患者中影像学与病理肿瘤大小差异对癌症特异性预后的影响
Eur J Surg Oncol. 2025 Jun;51(6):109683. doi: 10.1016/j.ejso.2025.109683. Epub 2025 Feb 10.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.经皮乙醇注射或经皮乙酸注射治疗早期肝细胞癌。
Cochrane Database Syst Rev. 2015 Jan 26;1(1):CD006745. doi: 10.1002/14651858.CD006745.pub3.
6
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.早期或极早期肝细胞癌患者的管理:一项网络荟萃分析尝试
Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2.
7
Tamoxifen for adults with hepatocellular carcinoma.他莫昔芬治疗肝细胞癌成人患者。
Cochrane Database Syst Rev. 2024 Aug 12;8(8):CD014869. doi: 10.1002/14651858.CD014869.pub2.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗:系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
10
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.

引用本文的文献

1
Radiologic and Pathologic Discordance in Hepatocellular Carcinoma: More Than a Mismatch, with Prognostic Significance.肝细胞癌的放射学与病理学不一致:不止是不匹配,具有预后意义。
Gut Liver. 2025 Jul 15;19(4):477-478. doi: 10.5009/gnl250293.

本文引用的文献

1
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.《2022年韩国肝脏癌协会-韩国国立癌症中心肝细胞癌管理实践指南》
J Liver Cancer. 2023 Mar;23(1):1-120. doi: 10.17998/jlc.2022.11.07. Epub 2022 Dec 9.
2
Radiological-histopathological discordance in patients transplanted for HCC and its impact on post-transplant outcomes.移植治疗 HCC 患者的影像学-组织病理学不相符及其对移植后结局的影响。
Cancer Med. 2023 Jul;12(14):15011-15025. doi: 10.1002/cam4.6161. Epub 2023 Jun 16.
3
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
美国肝病研究学会肝细胞癌预防、诊断和治疗实践指南。
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
4
Diagnosis of Metastatic Lymph Nodes in Patients With Hepatocellular Carcinoma Using Dual-Energy Computed Tomography.利用双能计算机断层扫描诊断肝细胞癌患者的转移性淋巴结
J Comput Assist Tomogr. 2023;47(3):355-360. doi: 10.1097/RCT.0000000000001429. Epub 2022 Dec 27.
5
Discordance between clinical and pathologic staging and the timeliness of care of non-small cell lung cancer patients diagnosed with operable tumors.临床分期与病理分期之间的不一致以及被诊断为可手术肿瘤的非小细胞肺癌患者的治疗及时性。
Asia Pac J Clin Oncol. 2023 Dec;19(6):706-714. doi: 10.1111/ajco.13934. Epub 2023 Jan 27.
6
Hepatocellular carcinoma.肝细胞癌
Lancet. 2022 Oct 15;400(10360):1345-1362. doi: 10.1016/S0140-6736(22)01200-4. Epub 2022 Sep 6.
7
Progress of MRI Radiomics in Hepatocellular Carcinoma.肝细胞癌磁共振成像放射组学的研究进展
Front Oncol. 2021 Sep 20;11:698373. doi: 10.3389/fonc.2021.698373. eCollection 2021.
8
The Discordance of Clinical and Pathologic Staging in Locally Advanced Gastric Adenocarcinoma.局部进展期胃腺癌临床分期与病理分期的不相符。
J Gastrointest Surg. 2021 Jun;25(6):1363-1369. doi: 10.1007/s11605-021-04993-4. Epub 2021 Apr 12.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
Discordance in prediction of prognosis among patients with intrahepatic cholangiocarcinoma: A preoperative vs postoperative perspective.肝内胆管细胞癌患者预后预测的不一致性:术前与术后视角。
J Surg Oncol. 2019 Nov;120(6):946-955. doi: 10.1002/jso.25671. Epub 2019 Aug 13.